newsfilter
← Latest News
GlobeNewswire·

Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day

Highlights advancing clinical-stage pipeline, including two major value-creating programs for primary immunodeficiencies (PIDs) with immune dysregulation and mtDNA-driven mitochondrial diseaseIntroduces napazimone